132 results on '"Maeda, Mayumi"'
Search Results
2. ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation
3. Flavor assessment of a lactic fermented vinegar described in Japanese books from the Edo period (1603–1867)
4. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
5. Sex and ethnic disparities in hepatitis B evaluation and treatment across the world
6. Isolation of Zygosaccharomyces siamensis kiy1 as a novel arabitol-producing yeast and its arabitol production
7. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study
8. Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients
9. d-Arabitol production by a high arabitol-producing yeast, Zygosaccharomyces sp. Gz-5 isolated from miso
10. De novo genome assembly and analysis of Zalaria sp. Him3, a novel fructooligosaccharides producing yeast
11. d-Arabitol production by a high arabitol-producing yeast, Zygosaccharomycessp. Gz-5 isolated from miso
12. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040
13. Phenolic acid decarboxylase of Aspergillus luchuensis plays a crucial role in 4-vinylguaiacol production during awamori brewing
14. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
15. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
16. Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease
17. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection
18. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study
19. Characterization and induction of phenolic acid decarboxylase from Aspergillus luchuensis
20. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
21. Su1551 CLINICAL PRESENTATION AND SURVIVAL IN MALE COMPARED TO FEMALE PATIENTS WITH CIRRHOSIS: A LONG-TERM COHORT STUDY OF 13,228 REAL-WORLD PATIENTS
22. Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study.
23. Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients
24. Flavor Assessment of a Lacto-Fermented Vinegar Described in Japanese Books from the Edo Period (1603–1867)
25. Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study
26. 328: REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY
27. Sa1396: ANTIVIRAL THERAPY IMPROVES SURVIVAL IN VIRAL-ASSOCIATED HEPATOCELLULAR CARCINOMA AFTER LIVER RESECTION BUT IS SEVERELY UNDERUTILIZED
28. Su1339: SEX DIFFERENCES IN VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A MULTICENTER LONGITUDINAL STUDY
29. Su1587 SUBOPTIMAL ASSESSMENT OF FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PRIMARY CARE VERSUS LIVER CLINIC SETTINGS
30. Sa1606 SEVERE UNDERUTILIZATION OF PALLIATIVE/HOSPICE CARE AND DISCUSSION AMONG PATIENTS WITH CIRRHOSIS INCLUDING THOSE WITH DECOMPENSATION AND HCC: FINDINGS FROM A SINGLE-CENTER REAL-WORLD STUDY OF 15.876 PATIENTS
31. Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice
32. Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma
33. Personality traits and BMI trends over three years in Japanese university students
34. Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir
35. Mo1527 VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG MALE AND FEMALE PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A REAL-B STUDY
36. Sa1578 NATURAL HISTORY OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG REAL-WORLD PATIENTS
37. Sa1552 ETHNIC DIFFERENCES IN LIVER AND MORTALITY OUTCOMES OF NONALCOHOLIC FATTY LIVER DISEASE: A REAL-WORLD STUDY WITH LONGITUDINAL FOLLOW-UP
38. Speciation of aluminum in rainwater using a fluoride ion-selective electrode and ion-exchange chromatography with fluorometric detection of the aluminum-lumogallion complex
39. Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma
40. Validity of International Classification of Diseases, Tenth Revision, Codes for Cirrhosis
41. High hepatitis C virus cure rates with approved interferon‐free direct‐acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
42. Modification of Step Ladder with Handrail for The Lower Extremity Venous Duplex Scanning
43. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West
44. Sa1520 DECREASED HEPATITIS B IMMUNITY IN CHILDREN AND ADOLESCENTS AND ANAMNESTIC RESPONSE TO BOOSTER VACCINATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
45. Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus
46. Validity of International Classification of Diseases, Tenth Revision, Codes for Cirrhosis.
47. Sa1610 – Differences and Factors Related to Nonalcoholic Fatty Liver Disease Progression Among Different Ethnicities: A Long-Term Longitudinal Study
48. Sa1613 – Clinical Characteristics and Long-Term Outcomes in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Among the Spectrum of Obesity: A Long-Term Longitudinal Study
49. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults
50. Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.